Engineered e. coli bacteria have been shown to shrink tumors in mice, potentially offering a new approach to cancer treatment. The bacteria may work by targeting specific pathways or types of tumors, although the exact mechanisms and potential applications are still being explored. It is unclear how this research relates to supportive care in young cancer patients or its potential to treat human diseases beyond cancer.